3-in-30: Recognizing Trends in ATTR-CM

Transthyretin amyloid cardiomyopathy (ATTR-CM) remains an underrecognized cause of cardiovascular disease, particularly among older adults. Recent US claims data offer insight into how its diagnosed incidence, prevalence, and associated clinical burden have changed over time.

3-in-30 is a quick quiz format designed for busy clinicians: three focused, evidence-based questions you can complete in 30 seconds. It’s a fast, practical way to reinforce clinical knowledge and stay sharp on core concepts.

Take 30 seconds and see how much you know.

©2026 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Consultant360 or HMP Global, their employees, and affiliates.